BioNTech SE - stock earnings
BNTX Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
Aug. 5, 2024 BeforeMarket | - / - | 71.3 million | - / 167.1 million | 334.4 million |
BNTX Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2024Q1 | -340.1 million USD | 202.5 million USD |
2023Q4 | 506.2 million USD | 1.6 billion USD |
2023Q3 | 170.0 million USD | 947.8 million USD |
2023Q2 | -207.0 million USD | 182.3 million USD |
2023Q1 | 547.4 million USD | 1.4 billion USD |
2022Q4 | 2.4 billion USD | 4.6 billion USD |
2022Q3 | 1.8 billion USD | 3.4 billion USD |
2022Q2 | 1.7 billion USD | 3.3 billion USD |
2022Q1 | 4.1 billion USD | 7.1 billion USD |
2021Q4 | 3.6 billion USD | 6.3 billion USD |
2021Q3 | 3.7 billion USD | 7.1 billion USD |
2021Q2 | 3.3 billion USD | 6.3 billion USD |
2021Q1 | 1.3 billion USD | 2.4 billion USD |
2020Q4 | 446.9 million USD | 420.7 million USD |
2020Q3 | -246.4 million USD | 79.1 million USD |
2020Q2 | -99.2 million USD | 46.9 million USD |
2020Q1 | -58.9 million USD | 30.5 million USD |
2019Q4 | -65.2 million USD | 31.4 million USD |
2019Q3 | -32.9 million USD | 31.4 million USD |
2019Q2 | -57.0 million USD | 29.3 million USD |
2019Q1 | -45.6 million USD | 29.4 million USD |
2018Q4 | -1.5 million USD | 73.0 million USD |
2018Q3 | -27.3 million USD | 23.7 million USD |
2018Q2 | -26.9 million USD | 50.2 million USD |
BNTX Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 1.0 billion USD | 4.2 billion USD |
2022 | 10.1 billion USD | 18.6 billion USD |
2021 | 11.7 billion USD | 21.6 billion USD |
2020 | 18.5 million USD | 587.4 million USD |
2019 | -200.7 million USD | 121.6 million USD |
2018 | -54.9 million USD | 145.9 million USD |
2017 | -102.3 million USD | 73.6 million USD |
BNTX
Price: $90.61
52 week price:
Earnings Per Share: 4.11 USD
P/E Ratio: 7.68
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 379200
Market Capitalization: 22.1 billion